Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

GATA4 Directly Regulates Runx2 Expression and Osteoblast Differentiation.

Khalid AB, Slayden AV, Kumpati J, Perry CD, Osuna MAL, Arroyo SR, Miranda-Carboni GA, Krum SA.

JBMR Plus. 2018 Mar;2(2):81-91. doi: 10.1002/jbm4.10027. Epub 2017 Nov 29.

2.

GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.

Khalid AB, Slayden AV, Kumpati J, Perry CD, Berryhill SB, Crawford JA, Fatima I, Morselli M, Pellegrini M, Miranda-Carboni GA, Krum SA.

Bone. 2018 Jul 19;116:78-86. doi: 10.1016/j.bone.2018.07.014. [Epub ahead of print]

3.

Correction: The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.

Fatima I, El-Ayachi I, Taotao L, Angeles Lillo M, Krutilina RI, Seagroves TN, Radaszkiewicz TW, Hutnan M, Bryja V, Krum SA, Rivas F, Miranda-Carboni GA.

PLoS One. 2018 May 17;13(5):e0197796. doi: 10.1371/journal.pone.0197796. eCollection 2018.

4.

Estrogens and selective estrogen receptor modulators differentially antagonize Runx2 in ST2 mesenchymal progenitor cells.

Amzaleg Y, Ji J, Kittivanichkul D, E Törnqvist A, Windahl S, Sabag E, Khalid AB, Sternberg H, West M, Katzenellenbogen JA, Krum SA, Chimge NO, Schones DE, Gabet Y, Ohlsson C, Frenkel B.

J Steroid Biochem Mol Biol. 2018 Oct;183:10-17. doi: 10.1016/j.jsbmb.2018.05.002. Epub 2018 May 8.

PMID:
29751107
5.

The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.

Fatima I, El-Ayachi I, Taotao L, Lillo MA, Krutilina R, Seagroves TN, Radaszkiewicz TW, Hutnan M, Bryja V, Krum SA, Rivas F, Miranda-Carboni GA.

PLoS One. 2017 Dec 27;12(12):e0189864. doi: 10.1371/journal.pone.0189864. eCollection 2017. Erratum in: PLoS One. 2018 May 17;13(5):e0197796.

6.

Bisphenol A Induces Sox2 in ER+ Breast Cancer Stem-Like Cells.

Lillo MA, Nichols C, Seagroves TN, Miranda-Carboni GA, Krum SA.

Horm Cancer. 2017 Apr;8(2):90-99. doi: 10.1007/s12672-017-0286-5. Epub 2017 Feb 27.

7.

Estrogens and androgens inhibit association of RANKL with the pre-osteoblast membrane through post-translational mechanisms.

Martin A, Yu J, Xiong J, Khalid AB, Katzenellenbogen B, Kim SH, Katzenellenbogen JA, Malaivijitnond S, Gabet Y, Krum SA, Frenkel B.

J Cell Physiol. 2017 Dec;232(12):3798-3807. doi: 10.1002/jcp.25862. Epub 2017 May 11.

8.

Methylparaben stimulates tumor initiating cells in ER+ breast cancer models.

Lillo MA, Nichols C, Perry C, Runke S, Krutilina R, Seagroves TN, Miranda-Carboni GA, Krum SA.

J Appl Toxicol. 2017 Apr;37(4):417-425. doi: 10.1002/jat.3374. Epub 2016 Sep 1.

9.

Estrogen receptors alpha and beta in bone.

Khalid AB, Krum SA.

Bone. 2016 Jun;87:130-5. doi: 10.1016/j.bone.2016.03.016. Epub 2016 Apr 9. Review.

10.

Glucocorticoids Hijack Runx2 to Stimulate Wif1 for Suppression of Osteoblast Growth and Differentiation.

Morimoto E, Li M, Khalid AB, Krum SA, Chimge NO, Frenkel B.

J Cell Physiol. 2017 Jan;232(1):145-53. doi: 10.1002/jcp.25399. Epub 2016 Apr 26.

11.

Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.

Martin A, Xiong J, Koromila T, Ji JS, Chang S, Song YS, Miller JL, Han CY, Kostenuik P, Krum SA, Chimge NO, Gabet Y, Frenkel B.

Bone. 2015 Jun;75:96-104. doi: 10.1016/j.bone.2015.02.007. Epub 2015 Feb 17.

12.

Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.

Drew BG, Hamidi H, Zhou Z, Villanueva CJ, Krum SA, Calkin AC, Parks BW, Ribas V, Kalajian NY, Phun J, Daraei P, Christofk HR, Hewitt SC, Korach KS, Tontonoz P, Lusis AJ, Slamon DJ, Hurvitz SA, Hevener AL.

J Biol Chem. 2015 Feb 27;290(9):5566-81. doi: 10.1074/jbc.M114.606459. Epub 2014 Dec 2.

13.

GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways.

Güemes M, Garcia AJ, Rigueur D, Runke S, Wang W, Zhao G, Mayorga VH, Atti E, Tetradis S, Péault B, Lyons K, Miranda-Carboni GA, Krum SA.

J Bone Miner Res. 2014 Dec;29(12):2676-87. doi: 10.1002/jbmr.2296.

14.

WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer.

Wend P, Runke S, Wend K, Anchondo B, Yesayan M, Jardon M, Hardie N, Loddenkemper C, Ulasov I, Lesniak MS, Wolsky R, Bentolila LA, Grant SG, Elashoff D, Lehr S, Latimer JJ, Bose S, Sattar H, Krum SA, Miranda-Carboni GA.

EMBO Mol Med. 2013 Feb;5(2):264-79. doi: 10.1002/emmm.201201320. Epub 2013 Jan 11.

15.

ERα regulates lipid metabolism in bone through ATGL and perilipin.

Wend K, Wend P, Drew BG, Hevener AL, Miranda-Carboni GA, Krum SA.

J Cell Biochem. 2013 Jun;114(6):1306-14. doi: 10.1002/jcb.24470.

16.

ERα signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis.

Garcia AJ, Tom C, Guemes M, Polanco G, Mayorga ME, Wend K, Miranda-Carboni GA, Krum SA.

J Bone Miner Res. 2013 Feb;28(2):283-90. doi: 10.1002/jbmr.1747.

17.

Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging.

Wend K, Wend P, Krum SA.

Front Endocrinol (Lausanne). 2012 Feb 8;3:19. doi: 10.3389/fendo.2012.00019. eCollection 2012.

18.

GATA4 regulates estrogen receptor-alpha-mediated osteoblast transcription.

Miranda-Carboni GA, Guemes M, Bailey S, Anaya E, Corselli M, Peault B, Krum SA.

Mol Endocrinol. 2011 Jul;25(7):1126-36. doi: 10.1210/me.2010-0463. Epub 2011 May 12.

19.

The role of WNT10B in physiology and disease.

Wend P, Wend K, Krum SA, Miranda-Carboni GA.

Acta Physiol (Oxf). 2012 Jan;204(1):34-51. doi: 10.1111/j.1748-1716.2011.02296.x. Epub 2011 May 7. Review.

PMID:
21447090
20.

Direct transcriptional targets of sex steroid hormones in bone.

Krum SA.

J Cell Biochem. 2011 Feb;112(2):401-8. doi: 10.1002/jcb.22970. Review.

Supplemental Content

Support Center